Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.975 USD | -2.45% | +16.14% | +7.55% |
May. 13 | Terns Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Terns Pharmaceuticals, Inc. Announces Executive Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.55% | 462M | |
+48.77% | 57.87B | |
+41.65% | 40.25B | |
-7.48% | 39.94B | |
-5.96% | 28.54B | |
+12.43% | 26.4B | |
-20.20% | 19.33B | |
+30.06% | 12.4B | |
-0.65% | 12.23B | |
+25.08% | 12.2B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- Terns Pharmaceuticals Gets Orphan Drug Label for Chronic Myeloid Leukemia Treatment Candidate